Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:1282-1289

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schultz, J. E. J.
Right arrow Articles by Gross, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schultz, J. E. J.
Right arrow Articles by Gross, G. J.

(Circulation. 1998;97:1282-1289.)
© 1998 American Heart Association, Inc.


Basic Science Reports

Ischemic Preconditioning in the Intact Rat Heart Is Mediated by {delta}1- But Not µ- or {kappa}-Opioid Receptors

Jo El J. Schultz, PhD; Anna K. Hsu, BS; ; Garrett J. Gross, PhD

From the Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee.

Correspondence to Garrett J. Gross, PhD, Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226.

Background—Our laboratory has previously shown that {delta}-opioid receptors are involved in the cardioprotective effect of ischemic preconditioning in the rat heart. However, this class of receptors consists of two subtypes, {delta}1 and {delta}2, and µ- or {kappa}-opioid receptors may also exist in the heart. Therefore, the purpose of the present study was to test the hypothesis that ischemic preconditioning is mediated through stimulation of one or both {delta}-opioid receptor subtypes.

Methods and Results—Anesthetized, open chest, male Wistar rats were assigned to 1 of 14 groups. All animals were subjected to 30 minutes of occlusion and 2 hours of reperfusion. Ischemic preconditioning was elicited by three 5-minute occlusion periods interspersed with 5 minutes of reperfusion. Two doses of 7-benzylidenenaltrexone (BNTX; 1 and 3 mg/kg IV), a selective {delta}1-opioid receptor antagonist, or naltriben (NTB; 1 and 3 mg/kg IV), a selective {delta}2-opioid receptor antagonist, were given before ischemic preconditioning. To test for a role of µ-opioid receptors, rats were pretreated with ß-funaltrexamine (ß-FNA; 15 mg/kg SC), an irreversible µ-opioid receptor antagonist, 24 hours before ischemic preconditioning or given the µ-opioid receptor agonist D-Ala,2N-Me-Phe,4glycerol5-enkephalin (DAMGO) as three 5-minute infusions (1, 10, and 100 µg/kg per infusion IV, respectively) interspersed with 5-minute drug-free periods before the prolonged ischemic and reperfusion periods (lowDAMGO, medDAMGO, and hiDAMGO, respectively). The involvement of {kappa}-opioid receptors was tested by administering one of two doses of nor-binaltorphimine (nor-BNI; 1 and 5 mg/kg IV) before ischemic preconditioning. Infarct size (IS) as a percent of the area at risk (AAR) was measured by triphenyltetrazolium stain. Ischemic preconditioning markedly reduced IS/AAR (14±4%, P<.05) compared with control (55±4%). NTB, ß-FNA, and nor-BNI were unable to block the cardioprotective effect of ischemic preconditioning. In addition, DAMGO had no effect on IS/AAR. However, the high dose of BNTX (3 mg/kg IV) significantly attenuated the cardioprotective effect of ischemic preconditioning (39±5%; P<.05 versus control and ischemic preconditioning).

Conclusions—These results indicate that {delta}1-opioid receptors play an important role in the cardioprotective effect of ischemic preconditioning in the rat heart.


Key Words: receptors • ischemia • myocardial infarction • signal transduction • heart diseases




This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. Lorsomradee, S. Cromheecke, S. Lorsomradee, and S. G De Hert
Cardioprotection with Volatile Anesthetics in Cardiac Surgery
Asian Cardiovasc Thorac Ann, June 1, 2008; 16(3): 256 - 264.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. J. Zatta, H. Kin, D. Yoshishige, R. Jiang, N. Wang, J. G. Reeves, J. Mykytenko, R. A. Guyton, Z.-Q. Zhao, J. L. Caffrey, et al.
Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1444 - H1451.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. H. Deo, M. A. Barlow, L. Gonzalez, D. Yoshishige, and J. L. Caffrey
Cholinergic location of {delta}-opioid receptors in canine atria and SA node
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H829 - H838.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. W. Dickson, C. P. Hogrefe, P. S. Ludwig, L. W. Ackermann, L. L. Stoll, and G. M. Denning
Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H402 - H408.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
C. K. Yu, Y.-H. Li, G. T. C. Wong, T. M. Wong, and M. G. Irwin
Remifentanil preconditioning confers delayed cardioprotection in the rat
Br. J. Anaesth., November 1, 2007; 99(5): 632 - 638.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Iwata, S. Inoue, M. Kawaguchi, M. Nakamura, N. Konishi, and H. Furuya
Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischaemia
Br. J. Anaesth., October 1, 2007; 99(4): 538 - 546.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M.-H. Huang, H.-Q. Wang, W. R. Roeske, Y. Birnbaum, Y. Wu, N.-P. Yang, Y. Lin, Y. Ye, D. J. McAdoo, M. G. Hughes, et al.
Mediating {delta}-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H376 - H384.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. H. Deo, S. Johnson-Davis, M. A. Barlow, D. Yoshishige, and J. L. Caffrey
Repeated {delta}1-opioid receptor stimulation reduces {delta}2-opioid receptor responses in the SA node
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2246 - H2254.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. H. Patel, B. P. Head, H. N. Petersen, I. R. Niesman, D. Huang, G. J. Gross, P. A. Insel, and D. M. Roth
Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and {delta}-opioid receptors
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H344 - H350.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z.-Q. Zhao and J. Vinten-Johansen
Postconditioning: Reduction of reperfusion-induced injury
Cardiovasc Res, May 1, 2006; 70(2): 200 - 211.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. A. Barlow, S. Deo, S. Johnson, and J. L. Caffrey
Vagotonic effects of enkephalin are not mediated by sympatholytic mechanisms.
Experimental Biology and Medicine, April 1, 2006; 231(4): 387 - 395.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Michael. J. Watson, J. D. S. Holt, S. J. O'Neill, K. Wei, W. Pendergast, G. J. Gross, P. J. Gengo, and K.-J. Chang
ARD-353 [4-((2R,5S)-4-(R)-(4-Diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic Acid], A Novel Nonpeptide {delta} Receptor Agonist, Reduces Myocardial Infarct Size without Central Effects
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 423 - 430.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Ockaili, R. Natarajan, F. Salloum, B. J. Fisher, D. Jones, A. A. Fowler III, and R. C. Kukreja
HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H542 - H548.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Barrere-Lemaire, N. Combes, C. Sportouch-Dukhan, S. Richard, J. Nargeot, and C. Piot
Morphine mimics the antiapoptotic effect of preconditioning via an Ins(1,4,5)P3 signaling pathway in rat ventricular myocytes
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H83 - H88.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Okubo, Y. Tanabe, K. Takeda, M. Kitayama, S. Kanemitsu, R. C. Kukreja, and N. Takekoshi
Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of {delta}-opioid receptor
Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1786 - H1791.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Horiuchi, M. Kawaguchi, T. Sakamoto, N. Kurita, S. Inoue, M. Nakamura, N. Konishi, and H. Furuya
The Effects of the {delta}-Opioid Agonist SNC80 on Hind-Limb Motor Function and Neuronal Injury After Spinal Cord Ischemia in Rats
Anesth. Analg., July 1, 2004; 99(1): 235 - 240.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Weinbrenner, F. Schulze, L. Sarvary, and R. H Strasser
Remote preconditioning by infrarenal aortic occlusion is operative via {delta}1-opioid receptors and free radicals in vivo in the rat heart
Cardiovasc Res, February 15, 2004; 61(3): 591 - 599.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. D. Addison, P. C. Neligan, H. Ashrafpour, A. Khan, A. Zhong, M. Moses, C. R. Forrest, and C. Y. Pang
Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1435 - H1443.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. F. K. Jackson, D. Yoshishige, and J. L. Caffrey
Bimodal {delta}-opioid receptors regulate vagal bradycardia in canine sinoatrial node
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1332 - H1339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Cao, L. Liu, and D. M. Van Winkle
Activation of {delta}- and {kappa}-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1032 - H1039.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. G. Pyle, Y. Chen, and P. A. Hofmann
Cardioprotection through a PKC-dependent decrease in myofilament ATPase
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1220 - H1228.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. N. Peart and G. J. Gross
Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors
Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H81 - H89.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Coles Jr., D. C. Sigg, and P. A. Iaizzo
Role of kappa -opioid receptor activation in pharmacological preconditioning of swine
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2091 - H2099.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Qin, J. M. Downey, and M. V. Cohen
Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H727 - H734.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Kodani, Y.-T. Xuan, K. Shinmura, H. Takano, X.-L. Tang, and R. Bolli
delta -Opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1943 - H1957.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
R. Kato and P. Foex
Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists: [La protection myocardique contre les lesions d'ischemie-reperfusion par des anesthesiques : une mise a jour pour les anesthesiologistes]
Can J Anesth, October 1, 2002; 49(8): 777 - 791.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. M Fryer, J. A Auchampach, and G. J Gross
Therapeutic receptor targets of ischemic preconditioning
Cardiovasc Res, August 15, 2002; 55(3): 520 - 525.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Y. Zhang, B. C. McPherson, H. Liu, T. Baman, S. S. McPherson, P. Rock, and Z. Yao
Role of Nitric-Oxide Synthase, Free Radicals, and Protein Kinase C delta in Opioid-Induced Cardioprotection
J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1012 - 1019.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. C. Sigg, J. A. Coles Jr., P. R. Oeltgen, and P. A. Iaizzo
Role of delta -opioid receptor agonists on infarct size reduction in swine
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1953 - H1960.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
K. E. Jackson, M. Farias, A. Stanfill, and J. L. Caffrey
Delta Opioid Receptors Inhibit Vagal Bradycardia in the Sinoatrial Node
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2001; 6(4): 385 - 393.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. M. Fryer, Y. Wang, A. K. Hsu, H. Nagase, and G. J. Gross
Dependence of delta 1-Opioid Receptor-Induced Cardioprotection on a Tyrosine Kinase-Dependent but Not a Src-Dependent Pathway
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 477 - 482.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Karck, S. Tanaka, S. F. Bolling, A. Simon, T.-P. Su, P. R. Oeltgen, and A. Haverich
Myocardial protection by ischemic preconditioning and {delta}-opioid receptor activation in the isolated working rat heart
J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 986 - 992.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. C. Sigg, J. A. Coles Jr, W. J. Gallagher, P. R. Oeltgen, and P. A. Iaizzo
Opioid preconditioning: myocardial function and energy metabolism
Ann. Thorac. Surg., November 1, 2001; 72(5): 1576 - 1582.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Schulz, M. V Cohen, M. Behrends, J. M Downey, and G. Heusch
Signal transduction of ischemic preconditioning
Cardiovasc Res, November 1, 2001; 52(2): 181 - 198.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. H. Patel and G. J. Gross
Diazoxide induced cardioprotection: what comes first, KATP channels or reactive oxygen species?
Cardiovasc Res, September 1, 2001; 51(4): 633 - 636.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. G. Pyle, J. W. Lester, and P. A. Hofmann
Effects of {kappa}-opioid receptor activation on myocardium
Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H669 - H678.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Schulz, P. Gres, and G. Heusch
Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2175 - H2181.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. A. Ockaili, P. Bhargava, and R. C. Kukreja
Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial KATP channel
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2406 - H2411.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. M. Fryer, P. F. Pratt, A. K. Hsu, and G. J. Gross
Differential Activation of Extracellular Signal Regulated Kinase Isoforms in Preconditioning and Opioid-Induced Cardioprotection
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 642 - 649.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. M. Fryer, Y. Wang, A. K. Hsu, and G. J. Gross
Essential activation of PKC-{delta} in opioid-initiated cardioprotection
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1346 - H1353.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. T. LEE and C. W. EMALA
Protein Kinase C and Gi/o Proteins Are Involved in Adenosine- and Ischemic Preconditioning--Mediated Renal Protection
J. Am. Soc. Nephrol., February 1, 2001; 12(2): 233 - 240.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G.-Y. Wang, S. Wu, J.-M. Pei, X.-C. Yu, and T.-M. Wong
{kappa}- but not {delta}-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H384 - H391.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Pepe
Dysfunctional ischemic preconditioning mechanisms in aging
Cardiovasc Res, January 1, 2001; 49(1): 11 - 14.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. P. Bell, M. N. Sack, A. Patel, L. H. Opie, and D. M. Yellon
Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2296 - 2302.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. G. Pyle, T. D. Smith, and P. A. Hofmann
Cardioprotection with kappa -opioid receptor stimulation is associated with a slowing of cross-bridge cycling
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1941 - H1948.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Younes, S. Pepe, B. A. Barron, H. A. Spurgeon, E. G. Lakatta, and J. L. Caffrey
Cardiac synthesis, processing, and coronary release of enkephalin-related peptides
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1989 - H1998.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. M. Fryer, A. K. Hsu, H. Nagase, and G. J. Gross
Opioid-Induced Cardioprotection against Myocardial Infarction and Arrhythmias: Mitochondrial versus Sarcolemmal ATP-Sensitive Potassium Channels
J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 451 - 457.
[Abstract] [Full Text]


Home page
CirculationHome page
M. V. Cohen, X.-M. Yang, T. Neumann, G. Heusch, and J. M. Downey
Favorable Remodeling Enhances Recovery of Regional Myocardial Function in the Weeks After Infarction in Ischemically Preconditioned Hearts
Circulation, August 1, 2000; 102(5): 579 - 583.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
W. E. Johnston
Preconditioning the Brain and Heart: Implications for Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 70 - 79.
[Abstract] [PDF]


Home page
Exp. Biol. Med.Home page
B. A. Barron
Cardiac Opioids
Experimental Biology and Medicine, May 1, 2000; 224(1): 1 - 7.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. M. Fryer, J. T. Eells, A. K. Hsu, M. M. Henry, and G. J. Gross
Ischemic preconditioning in rats: role of mitochondrial KATP channel in preservation of mitochondrial function
Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H305 - H312.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Ockaili, V. R. Emani, S. Okubo, M. Brown, K. Krottapalli, and R. C. Kukreja
Opening of mitochondrial KATP channel induces early and delayed cardioprotective effect: role of nitric oxide
Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2425 - H2434.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Takasaki, R. A. Wolff, G. L. Chien, and D. M. van Winkle
Met5-enkephalin protects isolated adult rabbit cardiomyocytes via delta -opioid receptors
Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2442 - H2450.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
H.-S. V. Chen, S. C. Body, and S. K. Shernan
Myocardial Preconditioning: Characteristics, Mechanisms, and Clinical Applications
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1999; 3(2): 85 - 97.
[Abstract] [PDF]


Home page
Circ. Res.Home page
S. Wu, H. Y. Li, and T. M. Wong
Cardioprotection of Preconditioning by Metabolic Inhibition in the Rat Ventricular Myocyte : Involvement of {kappa}-Opioid Receptor
Circ. Res., June 25, 1999; 84(12): 1388 - 1395.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. T. Liang and G. J. Gross
Direct Preconditioning of Cardiac Myocytes via Opioid Receptors and KATP Channels
Circ. Res., June 25, 1999; 84(12): 1396 - 1400.
[Abstract] [Full Text] [PDF]


Home page